Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEGON LTD.AEG · Entity 3394 | Director | September 24, 2026 | September 28, 2026 |
| DXC Technology CoDXC · Entity 4594 | Director | August 04, 2026 | August 06, 2026 |
| METLIFE INCMET · Entity 488 | Director | April 01, 2025 | April 03, 2025 |
| OCTAVE SPECIALTY GROUP INCAMBC · Entity 6308 | Director | April 03, 2023 | April 04, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEGON LTD.
Report date September 24, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 24,985 |
Reported balance
After 2026-09-24 transaction · row 1
1 source rowRow 1 · 2026-09-24 · Grant · Acquired 257 · Balance 24,985 F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of dividend equivalent shares associated with the Reporting Person's outstanding equity awards.
DXC Technology Co
Report date August 04, 2026 · Filed August 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 147,301 |
Reported balance
After 2026-08-04 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-08-04 · Grant · Acquired 30,900 · Balance 147,301 F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2: Amount reported includes unvested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the 2027 annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.
F2: Amount reported includes unvested RSUs.
METLIFE INC
Report date April 01, 2025 · Filed April 03, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,138 |
Reported balance
After 2025-04-01 transaction · row 1
1 source rowRow 1 · 2025-04-01 · Grant · Acquired 218 · Balance 26,138 F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. F2: The amount reported reflects a prorated portion of the non-management director retainer fees beginning April 1, 2025 and ending May 1, 2025, the effective date of the director's resignation from the Board. |
| Common StockSEC Table I · non-derivative | Indirectby David L. Herzog Trust | 87 |
Reported balance
Holding disclosure · report date 2025-04-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 87 |
Filing footnotes · ownership attribution and instrument terms
F1: MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
F2: The amount reported reflects a prorated portion of the non-management director retainer fees beginning April 1, 2025 and ending May 1, 2025, the effective date of the director's resignation from the Board.
OCTAVE SPECIALTY GROUP INC
Report date April 03, 2023 · Filed April 04, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 93,057 |
Reported balance
After 2023-04-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-04-03 · Grant · Acquired 3,277 · Balance 93,057 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company").
F2: RSU's granted on April 3, 2023 shall vest one year later on April 3, 2024. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 10, 2021 Filed Nov 12, 2021 13:45 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 3,051 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-21-000159 · wf-form4_163672474353898.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,632 Underlying: Common Stock · 3,051 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on November 10, 2021 shall vest one year later on November 10, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on November 10, 2021 shall vest one year later on November 10, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 20:32 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 600 | $62.52 | $37,512.00 |
DisclosureSEC source: 0001099219-21-000324 · wf-form4_163346592525200.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,214 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 20:37 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 43 | $60.78 | $2,613.54 |
DisclosureSEC source: 0001099219-21-000289 · wf-form4_163182463983085.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,614 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| August 20, 2021 Filed Aug 24, 2021 21:30 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 5,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-21-000066 · wf-form4_162984059887690.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,706 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| August 09, 2021 Filed Aug 10, 2021 20:09 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 3,437 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-21-000133 · wf-form4_162862613960335.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,581 Underlying: Common Stock · 3,437 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on August 9, 2021 shall vest one year later on August 9, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on August 9, 2021 shall vest one year later on August 9, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 21:13 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 589 | $63.77 | $37,560.53 |
DisclosureSEC source: 0001099219-21-000243 · wf-form4_162396434125807.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,571 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 00:56 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 41 | $63.31 | $2,595.71 |
DisclosureSEC source: 0001099219-21-000211 · wf-form4_162389137119693.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,982 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| May 12, 2021 Filed May 12, 2021 20:10 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 2,936 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-21-000089 · wf-form4_162085024078071.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,144 Underlying: Common Stock · 2,936 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on May 12, 2021 shall vest one year later on May 12, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on May 12, 2021 shall vest one year later on May 12, 2022. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 20:50 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 609 | $61.60 | $37,514.40 |
DisclosureSEC source: 0001099219-21-000156 · wf-form4_161765579714384.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,942 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| March 15, 2021 Filed Mar 17, 2021 20:56 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 41 | $60.54 | $2,482.14 |
DisclosureSEC source: 0001099219-21-000124 · wf-form4_161601456915406.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,333 F1 · kind: Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred. Read SEC document |
| January 04, 2021 Filed Jan 5, 2021 21:25 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 814 | $46.08 | $37,509.12 |
DisclosureSEC source: 0001099219-21-000026 · wf-form4_160988188363660.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,292 F1 · kind: MetLife, Inc.'s non-management director compensation arrangements pay 50% of non-management director retainer fees in MetLife, Inc. common stock. Read SEC document |
| December 14, 2020 Filed Dec 16, 2020 22:07 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 53 | $45.84 | $2,429.52 |
DisclosureSEC source: 0001099219-20-000382 · wf-form4_160815641588069.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,478 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 21:39 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 1,007 | $37.26 | $37,520.82 |
DisclosureSEC source: 0001099219-20-000345 · wf-form4_160193392776134.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,425 F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| September 14, 2020 Filed Sep 16, 2020 20:26 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 62 | $38.84 | $2,408.08 |
DisclosureSEC source: 0001099219-20-000314 · wf-form4_160028798229966.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,418 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| August 18, 2020 Filed Aug 20, 2020 22:23 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 10,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-20-000068 · wf-form4_159796217923295.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,106 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:50 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 970 | $38.69 | $37,529.30 |
DisclosureSEC source: 0001099219-20-000270 · wf-form4_159251341407130.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,356 F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| June 12, 2020 Filed Jun 16, 2020 20:57 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 63 | $37.45 | $2,359.35 |
DisclosureSEC source: 0001099219-20-000236 · wf-form4_159234102229723.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,386 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| April 30, 2020 Filed May 1, 2020 20:10 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 11,628 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-20-000066 · wf-form4_158836380645066.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,208 Underlying: Common Stock · 11,628 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on April 30, 2020 shall vest one year later on April 30, 2021. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on April 30, 2020 shall vest one year later on April 30, 2021. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| April 01, 2020 Filed Apr 2, 2020 21:19 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 1,345 | $27.90 | $37,525.50 |
DisclosureSEC source: 0001099219-20-000176 · wf-form4_158586236348085.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,323 F1 · kind: The reporting person acquired these shares under MetLife, Inc.'s non-management director compensation arrangements, which provide for 50% of non-management director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| March 13, 2020 Filed Mar 18, 2020 01:12 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 70 | $31.93 | $2,235.10 |
DisclosureSEC source: 0001099219-20-000158 · wf-form4_158449395130755.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,978 F1 · kind: Represents imputed reinvestment of dividends on deferred shares in the reporting person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 21:49 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 727 | $51.62 | $37,527.74 |
DisclosureSEC source: 0001099219-20-000040 · wf-form4_157834732576594.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,908 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in MetLife, Inc. common stock. Read SEC document |
| December 13, 2019 Filed Dec 17, 2019 21:49 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 44 | $50.38 | $2,216.72 |
DisclosureSEC source: 0001099219-19-000253 · wf-form4_157661935347865.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,181 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| October 01, 2019 Filed Oct 3, 2019 20:46 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 815 | $46.03 | $37,514.45 |
DisclosureSEC source: 0001099219-19-000208 · wf-form4_157013556720627.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,137 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| September 13, 2019 Filed Sep 17, 2019 20:46 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 38 | $48.37 | $1,838.06 |
DisclosureSEC source: 0001099219-19-000167 · wf-form4_156875319746296.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,322 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| August 20, 2019 Filed Aug 21, 2019 22:27 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-19-000094 · wf-form4_156642644491247.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,406 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| August 20, 2019 Filed Feb 28, 2020 21:57 UTC Amendment | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 5,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-20-000010 · wf-form4a_158292703596064.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,806 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · shares: This Form 4 is being amended to correct the number of RSUs awarded from 6,500 RSUs to 5,900 RSUs. F3 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| June 18, 2019 Filed Jun 20, 2019 20:52 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 770 | $48.71 | $37,506.70 |
DisclosureSEC source: 0001099219-19-000119 · wf-form4_156106392570998.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,284 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| June 13, 2019 Filed Jun 17, 2019 22:55 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 31 | $48.51 | $1,503.81 |
DisclosureSEC source: 0001099219-19-000070 · wf-form4_156081211961898.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,514 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| April 30, 2019 Filed May 1, 2019 20:54 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 10,696 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-19-000052 · wf-form4_155674404091705.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,580 Underlying: Common Stock · 10,696 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on April 30, 2019 shall vest one year later on April 30, 2020. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on April 30, 2019 shall vest one year later on April 30, 2020. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| April 01, 2019 Filed Apr 2, 2019 20:39 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 850 | $44.13 | $37,510.50 |
DisclosureSEC source: 0001209191-19-022551 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,483 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| March 13, 2019 Filed Mar 14, 2019 20:38 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 24 | $44.70 | $1,072.80 |
DisclosureSEC source: 0001209191-19-019468 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,633 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 21:30 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 900 | $41.67 | $37,503.00 |
DisclosureSEC source: 0001209191-19-001973 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,609.2856 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| December 13, 2018 Filed Dec 14, 2018 21:23 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 16.9965 | $39.52 | $671.70 |
DisclosureSEC source: 0001209191-18-062723 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,709.2856 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| October 01, 2018 Filed Oct 3, 2018 21:29 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 802 | $46.77 | $37,509.54 |
DisclosureSEC source: 0001209191-18-054009 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,692.2891 F1 · kind: The Reporting Person acquired these Deferred Shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock, and the MetLife Deferred Compensation Plan for Non-Management Directors, under which Directors may elect to defer receipt of such stock for a specific period of time. Read SEC document |
| September 13, 2018 Filed Sep 17, 2018 20:49 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 7.2891 | $45.52 | $331.80 |
DisclosureSEC source: 0001209191-18-051226 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,890.2891 F1 · kind: Represents imputed reinvestment of dividends on Deferred Shares in the Reporting Person's deferral account pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred Shares represent shares of MetLife, Inc. common stock that have become payable, but that remain unpaid because payment has been deferred. Read SEC document |
| August 20, 2018 Filed Aug 22, 2018 23:48 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-18-000100 · wf-form4_153498168907553.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,906 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2 · balance_after: Amount reported includes unvested RSUs. F3 · balance_after: Pursuant to the anti-dilution provisions of the registrant's 2017 Non-Employee Director Incentive Plan, the amount of securities beneficially owned has been adjusted in connection with the spin-off of the registrant's United States Public Sector business. A conversion ratio of 0.8649 was applied to the August 15, 2017 award of 2,300 RSUs (the "2017 Award") that remained unvested at the time of the spin-off. As a result, the reporting person received 359 additional RSUs. The 2017 Award vested in full on August 15, 2018. Read SEC document |
| June 12, 2018 Filed Jun 14, 2018 20:41 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 790 | $47.49 | $37,517.10 |
DisclosureSEC source: 0001209191-18-037748 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,883 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| April 30, 2018 Filed May 1, 2018 21:23 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 11,744 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-18-000051 · wf-form4_152520982192112.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,884 Underlying: Common Stock · 11,744 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on April 30, 2018 shall vest one year later on April 30, 2019. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on April 30, 2018 shall vest one year later on April 30, 2019. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| April 02, 2018 Filed Apr 4, 2018 20:23 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 833 | $45.02 | $37,501.66 |
DisclosureSEC source: 0001209191-18-023635 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,093 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 21:18 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 748 | $50.18 | $37,534.64 |
DisclosureSEC source: 0001209191-18-001931 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,260 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of non-management Director retainer fees to be paid in company common stock. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:18 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 720 | $52.14 | $37,540.80 |
DisclosureSEC source: 0001209191-17-055805 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,512 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock. Read SEC document |
| August 15, 2017 Filed Aug 17, 2017 20:42 UTC | DXC Technology Co DXC · Entity 4594 | GrantCommon Stock | 2,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-17-000189 · wf-form4_150300255477349.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,247 F1 · shares: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F1 · price: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F2 · balance_after: Amount reported includes unvested RSUs. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 20:55 UTC | DXC Technology Co DXC · Entity 4594 | Exercise / conversionRestricted Stock Units · Derivative | 900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001688568-17-000172 · wf-form4_150274411544163.xml · derivative · entry 2 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 900 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs vested and settled at the annual meeting of stockholders held on August 10, 2017. F1 · derivative.expiration_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs vested and settled at the annual meeting of stockholders held on August 10, 2017. Read SEC document |
| August 10, 2017 Filed Aug 14, 2017 20:55 UTC | DXC Technology Co DXC · Entity 4594 | Exercise / conversionCommon Stock | 900 | $0.00 | $0.00 |
DisclosureSEC source: 0001688568-17-000172 · wf-form4_150274411544163.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 947 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs vested and settled at the annual meeting of stockholders held on August 10, 2017. Read SEC document |
| June 13, 2017 Filed Jun 15, 2017 20:19 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 704 | $53.31 | $37,530.24 |
DisclosureSEC source: 0001209191-17-040123 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,792 F1 · kind: The Reporting Person acquired these shares under MetLife, Inc.'s non-management Director compensation arrangements, which provide for 50% of annual retainer fees to be paid in company common stock. Read SEC document |
| May 15, 2017 Filed May 17, 2017 21:53 UTC | DXC Technology Co DXC · Entity 4594 | GrantRestricted Stock Units · Derivative | 900 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001688568-17-000073 · wf-form4_149505797656313.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 900 Underlying: Common Stock · 900 shares Expires not disclosed F1 · derivative.exercise_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. F1 · derivative.expiration_date: Each Restricted Stock Unit (RSU) entitles the reporting person to receive one share of common stock upon the vesting date. The RSUs will vest and settle the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. Read SEC document |
| April 28, 2017 Filed May 1, 2017 21:44 UTC | OCTAVE SPECIALTY GROUP INC AMBC · Entity 6308 | GrantRestricted Stock Units · Derivative | 10,294 | $0.00 | $0.00 |
DisclosureSEC source: 0000874501-17-000048 · wf-form4_149367507158519.xml · derivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,140 Underlying: Common Stock · 10,294 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the common stock of Ambac Financial Group, Inc. (the "Company"). F2 · derivative.exercise_date: RSU's granted on April 28, 2017 shall vest one year later on April 30, 2018. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. F2 · derivative.expiration_date: RSU's granted on April 28, 2017 shall vest one year later on April 30, 2018. RSUs that have become vested shall settle and convert into shares of common stock upon the date that the reporting person resigns from, or otherwise ceases to be a member of, the Board of Directors of the Company. Read SEC document |
| October 21, 2016 Filed Oct 25, 2016 20:18 UTC | METLIFE INC MET · Entity 488 | GrantCommon Stock | 2,088 | $46.38 | $96,841.44 |
DisclosureSEC source: 0001209191-16-146859 · doc4.xml · nonDerivative · entry 1 Herzog David L · CIK 0001331793 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,088 F1 · kind: Under the Company's Non-Management Director Stock Compensation arrangements, 50% of the Annual Retainer Fee is paid in the Company's common stock. This is a pro rata amount for the period starting October 21, 2016 and ending June 12, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.